Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Oct;124(4):1118-1124.
doi: 10.1097/PRS.0b013e3181b5a349.

Effect of sustained-release PDGF and TGF-beta on cyclophosphamide-induced impaired wound healing

Azra Ashraf  1 , Peter H U Lee, Kyoung Kim, Victor Zaporojan, Lawrence Bonassar, Robert Valentini, Anthony Spangenberger, Jeffrey Weinzweig
Affiliations

Effect of sustained-release PDGF and TGF-beta on cyclophosphamide-induced impaired wound healing

Azra Ashraf et al. Plast Reconstr Surg. 2009 Oct.

Erratum in

  • Plast Reconstr Surg. 2010 Jan;125(1):426-7

Abstract

Background: Proper wound healing is pivotal to successful surgical outcomes. Previous studies have shown that growth factors can be used to enhance tissue repair under impaired healing conditions. However, because of limited delivery methods, the growth factors in these studies were delivered either topically or as a single local administration.

Methods: Sixty Sprague-Dawley rats were divided equally into five groups and served as untreated normal controls or were implanted subcutaneously with a novel sustained-release drug delivery system through a dorsal incisional wound. This system delivered either transforming growth factor (TGF)-beta alone, platelet-derived growth factor (PDGF) alone, or TGF-beta and PDGF in combination, or served as unloaded sham controls. Wound healing was impaired in all treated rats by the administration of cyclophosphamide on days 1, 3, and 5. Wound tensile breaking strength was determined on days 4, 7, and 14.

Results: Sustained release of either TGF-beta or PDGF alone not only failed to improve the healing of cyclophosphamide-induced impaired wound healing but resulted in a paradoxical decrease in wound tensile breaking strength by day 7. However, the combined delivery of both TGF-beta and PDGF improved wound healing and significantly increased wound tensile breaking strength by day 7.

Conclusions: Sustained-release delivery of TGF-beta and PDGF in combination, but not separately, by a subcutaneously implanted drug delivery system significantly improves cyclophosphamide-induced impaired wound healing in rats.

PubMed Disclaimer

References

    1. Broughton G, Janis JE, Attinger CE. Wound healing: An overview. Plast Reconstr Surg. 2006;117(Suppl):1e–32e.
    1. Riss J, Khanna C, Koo S, et al. Cancers as wounds that do not heal: Differences and similarities between renal regeneration/repair and renal cell carcinoma. Cancer Res. 2006;66:7216–7224.
    1. Frangogiannis NG. Targeting the inflammatory response in healing myocardial infarcts. Curr Med Chem. 2006;13:1877–1893.
    1. Holman DM, Kalaaji AN. Cytokines in dermatology. J Drugs Dermatol. 2006;5:520–524.
    1. Ross R, Glomset J, Kariya B, Harker L. A platelet-dependent serum factor that stimulates the proliferation of arterial smooth muscle cells in vitro. Proc Natl Acad Sci USA. 1974;71:1207–1210.

MeSH terms

Substances

LinkOut - more resources